COAPTITE Injectable Implant, injectable, sterile, non-pyrogenic implant composed of spherical par...
FDA Device Recall #Z-0401-2021 — Class II — September 30, 2020
Recall Summary
| Recall Number | Z-0401-2021 |
| Classification | Class II — Moderate risk |
| Date Initiated | September 30, 2020 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Merz North America, Inc. |
| Location | Franksville, WI |
| Product Type | Devices |
| Quantity | 2051 units |
Product Description
COAPTITE Injectable Implant, injectable, sterile, non-pyrogenic implant composed of spherical particles (75-125 microns in diameter of calcium hydroxylapatite (CaHA), suspended in aqueous based gel carrier. Gel carrier is composed of sodium carboxymethylcellulose, sterile water for injection, and glycerin. Product is packaged in a 1.0cc syringe and packed in a sterile pouch.
Reason for Recall
The Instructions for Use (IFU) updated 03/02/2020 does not match data listed in the post-approval study.
Distribution Pattern
US only distribution - AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV
Lot / Code Information
Model M0068903000, Lots: 100127846, 100127847, 100128709, 100128710, 100129357, 100129614, and 100129615
Other Recalls from Merz North America, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2607-2016 | Class II | Radiesse (+) Lidocaine, Injectable Implant 1.5c... | May 20, 2016 |
| Z-0368-2016 | Class II | PROLARYN PLUS Injectable Implant 1.0 cc Plus Ca... | Oct 26, 2015 |
| Z-0366-2016 | Class II | Radiesse (+) Lidocaine Injectable Implant 1.5cc... | Oct 26, 2015 |
| Z-0367-2016 | Class II | PROLARYN Injectable Implant 1.0 cc Gel, Model N... | Oct 26, 2015 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.